Authors


S. Barry Eiden, OD, FAAO

Latest:

International Keratoconus Academy continues to provide cutting-edge education

Over the years, IKA has become an invaluable resource for eye care professionals.


Ehsan Sadri, MD, FACS

Latest:

(Part 2) From ophthalmology’s lockdown to lasting change: The pandemic habits that stuck

From revised patient flow to smarter tech adoption, ophthalmologists share which changes from 2020 have become cornerstones of modern care—and how they’re preparing for the next big disruption


Matthew Roe, MD, MHS

Latest:

Big data drives opportunity for real-world evidence

Evidence-based medicine can lead to personalized care, better results for patients


Alex Choi

Latest:

ARVO 2025: Multimodal retinal imaging in asymptomatic APOE ε4 carriers, noncarriers, and Alzheimer Disease

At ARVO 2025, in Salt Lake City, Utah, Alex Choi discussed his poster on APOE carrier genetic status and its relation to Alzheimer disease as well as changes of the retina that might reflect early signs leading to an earlier diagnosis of the disease



Juan Carlos Navia, MD

Latest:

Surgical innovation in dry eye disease: Salivary gland transplant

A novel use of minor salivary glands offers lasting relief and visual improvement.


Dain B. Brooks, MD

Latest:

Surgical options for normalizing neuroadaptation in patients

Technical details, communication style key to presbyopia-correcting IOL journey.


Alon Kahana, MD, PhD

Latest:

Pearls for the treatment of patients with neurotrophic keratitis

Optimizing corneal neurotization outcomes with cryopreserved amniotic membrane.


Andrew D. Pucker, OD, PhD, FAAO

Latest:

The future of decentralized clinical trials in ophthalmology

Research can drive opportunities for patients with rare diseases


W. Lloyd Clark, MD

Latest:

ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTS

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.


Fatema Ghasia, MD

Latest:

AI and eye tracking: Technological companions to assess amblyopia in pediatric patients

These tools help fill a gap that current technologies cannot achieve as effectively.


Kenneth A. Beckman, MD, FACS

Latest:

World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD

Epi-on corneal crosslinking is advancing through innovations like supplemental oxygen, chemical oxygenation, and laser-assisted techniques.


Grazia Pertile, MD

Latest:

Retinal detachments: managing retinal folds, role of anterior vitreous

Grazia Pertile, MD, discusses the highlights of her presentations on the management of retinal folds after retinal detachment and the role of the anterior vitreous as a cause of recurrent retinal detachment.


Patipol Tiyajamorn

Latest:

ARVO 2025: Using graph neural networks to differentiate between fast and slow glaucoma progressors

At ARVO 2025, in Salt Lake City, Utah, Patipol Tiyajamorn, talked about his poster on using graph neural networks to identify fast glaucoma progressors solely using optic nerve head morphology at a single time point


Larissa Camejo, MD

Latest:

MicroPulse TLT offers proven versatility in the practice

Ophthalmologist offers pearls for use of technology in daily work.


Danielle Gauthier

Latest:

ARVO 2025: Association between autosomal dominant Alzheimer disease and optic nerve head drusen

At ARVO 2025, in Salt Lake City, Utah, Danielle Gauthier talked about her poster on autosomal dominant Alzheimer disease in relation to optic nerve head drusen.


Shigeru Kinoshita, MD, PhD

Latest:

Innovation and the clinician-scientist

A discussion with Shigeru Kinoshita, MD, PhD; and Edward J. Holland, MD.


Scott D. Walter, MD, MSc, FASRS

Latest:

Final Thoughts on Case Presentations and Advanced Therapies

Retinal specialists conclude their discussion with key highlights from each patient case of retinal vascular disease and pearls the audience can apply in their practice.


Panayiota Founti, PhD, FEBO

Latest:

Patient glaucoma management focuses on pivotal studies

Randomly assigned controlled trials key in increasing understanding of disease.


Eva Kim, MD

Latest:

50 years of ophthalmology: What changed the game (Part 2)

Ophthalmologists discuss the most impactful advancements reshaping patient care over five decades.


Sara Wester, MD

Latest:

Envision Summit 2025: Women leaders in eye health

At the Envision Summit 2025 in San Juan, Puerto Rico, Sara Wester, MD, discussed the Women Leaders in Eye Health session at the conference and the donation from Orbis that supported the session.


Thomas W. Samuelson, MD

Latest:

Thomas W. Samuelson, MD, shares clinical perspectives on DSLT, SLT, and glaucoma management

Direct selective laser trabeculoplasty enhances the experience for both patients and physicians, he notes, while also mitigating issues related to poor adherence and ocular surface disease from topical therapy.


Luke Lindsell, OD, MD

Latest:

At CIME 2025, Luke Lindsell, OD, MD, shares thoughts on comanaging challenging retina cases

In this Q&A, Luke Lindsell, OD, MD, shares his insights on emerging therapies in retina, the evolving role of optometrists in retinal disease management, and the importance of comanagement in patient care.


Wendy Lee, MD

Latest:

CIME 2025: Wendy Lee, MD, MS, emphasizes the power of a referral to an oculoplastics surgeon

Wendy Lee, MD, MS, shares how she integrates aesthetic and functional care in oculoplastics.


Paul Badawi

Latest:

What’s Your WhEYE? A conversation with Paul Badawi, CEO of Sight Sciences

Paul Badawi, co-founder and CEO of Sight Sciences, sits down with host Neda Shamie, MD, to discuss his journey into the field of eye care, what motivates him, the transformative approach to glaucoma patient care, and the spark that led him and his ophthalmologist brother, David Badawi, MD, to start the company together.


Joel S. Schuman, MD

Latest:

CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23

President Joel S. Schuman, MD, highlights the group’s mission and vision for the future—uniting 17 working groups and over 80 stakeholders.


Farhad Hafezi, MD, PhD, FARVO

Latest:

Transforming the eye with a new standard for corneal cross-linking

The new standard: Stabilizing keratoconus and improving vision.


Yuhua Zhang, PhD

Latest:

ARVO 2025: Adaptive optics imaging of AMD

At ARVO 2025, in Salt Lake City, Utah, Yuhua Zhang, PhD, talked about his presentation on in vivo imaging of retinal pigment epithelium metabolic function in age-related macular degeneration


Taylor Strange, DO

Latest:

ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases

Use of the LENSAR Ally femtosecond laser for arcuate incisions was associated with improved early visual outcomes and reduced need for postoperative adjustments in premium IOL patients.


Joaquin De Rojas, MD

Latest:

50 years of ophthalmology: What changed the game (Part 2)

Ophthalmologists discuss the most impactful advancements reshaping patient care over five decades.

© 2025 MJH Life Sciences

All rights reserved.